Pandox’s CEO Anders Nissen has acquired in total 600,000 synthetic options from Eiendomsspar AS, CGS Holding AS and Helene Sundt AS. The options have a term of approx. five years and the issuers have the possibility to, provided that the exercise price is reached, determine whether the options shall be cash settled or entitle to B-shares in Pandox. The options have been acquired on market terms. The price per option is SEK 2.17 and has been calculated in accordance with the Black-Scholes valuation model. The exercise price per option has been set to SEK 154.85, there is a cap per option of SEK 246.53 and the total profit can be a maximum of approx. SEK 55.01 million.

Pandox is not involved in the issuance of the options and no costs are expected to be incurred for Pandox as a result of the options. Being options issued by shareholders, there will not be any dilution for other shareholders.

After the acquisition of options, Anders Nissen holds 371,250 A- and B-shares, which are either held directly or indirectly through a wholly-owned company, and 1,190,877 options.